BENJAMIN STEPHENS: Open Payments
NPI 1568993582 · CHARLOTTESVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$506 in 24 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $506
Food & beverage: $506
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $100 |
| Supernus Pharmaceuticals, Inc. | 3 | $73 |
| Lundbeck LLC | 2 | $49 |
| Vanda Pharmaceuticals Inc. | 2 | $47 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| Collegium Pharmaceutical, Inc. | 2 | $39 |
| Alkermes, Inc. | 2 | $33 |
| ABBVIE INC. | 2 | $32 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
Products named: REXULTI, Qelbree, ABILIFY ASIMTUFII, UZEDY, Jornay PM, ARISTADA, VRAYLAR, FANAPT.
Industry payments across VA — which companies pay providers there.
